Ocular surface toxicity associated with topical interferon alpha-2b.
作者信息
Aldave Anthony J, Nguyen Anne
出版信息
Br J Ophthalmol. 2007 Aug;91(8):1087-8. doi: 10.1136/bjo.2006.107482.
Abstract
摘要
相似文献
1
Ocular surface toxicity associated with topical interferon alpha-2b.与局部应用干扰素α-2b相关的眼表毒性。
Br J Ophthalmol. 2007 Aug;91(8):1087-8. doi: 10.1136/bjo.2006.107482.
2
Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.局部应用干扰素α-2b治疗23例眼表鳞状上皮肿瘤：基于美国癌症联合委员会分类的结果
Arch Ophthalmol. 2012 Feb;130(2):159-64. doi: 10.1001/archophthalmol.2011.385.
3
Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.经活检证实的结膜上皮内瘤变采用局部应用干扰素α-2b进行治疗。
Br J Ophthalmol. 2005 Sep;89(9):1221. doi: 10.1136/bjo.2004.063339.
4
Topical medical therapies for ocular surface tumors.眼表肿瘤的局部药物治疗
Semin Ophthalmol. 2006 Jul-Sep;21(3):161-9. doi: 10.1080/08820530500351694.
5
Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.局部应用干扰素 alpha 2b 滴眼剂治疗眼表面鳞状上皮肿瘤：剂量比较研究。
Br J Ophthalmol. 2010 May;94(5):551-4. doi: 10.1136/bjo.2008.153197. Epub 2009 Jun 2.
6
Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.丝裂霉素 C 和干扰素 α-2b 局部治疗后眼表鳞状细胞癌复发的危险因素。
Am J Ophthalmol. 2014 Feb;157(2):287-293.e2. doi: 10.1016/j.ajo.2013.10.012. Epub 2013 Nov 1.
7
Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.局部应用干扰素α-2b单一疗法治疗原发性眼表鳞状上皮肿瘤
Asia Pac J Ophthalmol (Phila). 2015 Sep-Oct;4(5):279-82. doi: 10.1097/APO.0000000000000104.
8
Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.局部应用干扰素α-2b治疗复发性角膜和结膜上皮内瘤变
Ophthalmology. 2004 Sep;111(9):1755-61. doi: 10.1016/j.ophtha.2004.01.034.
9
Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.局部应用干扰素α-2b治疗结膜和角膜上皮内瘤变的长期随访
Ophthalmology. 2008 Aug;115(8):1291-6, 1296.e1. doi: 10.1016/j.ophtha.2007.10.039. Epub 2008 Jan 9.
10
[Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].[眼表上皮肿瘤的辅助性局部应用干扰素-α-2b治疗]
Ophthalmologe. 2006 Feb;103(2):124-8. doi: 10.1007/s00347-005-1249-8.
引用本文的文献
1
Presumed reactivation of herpes simplex virus-associated endothelial keratitis after treatment with topical interferon-α 2b for ocular surface squamous neoplasia.在用局部干扰素-α 2b治疗眼表鳞状上皮瘤后，推测单纯疱疹病毒相关性内皮性角膜炎复发。
BMC Ophthalmol. 2025 Apr 9;25(1):191. doi: 10.1186/s12886-025-04039-2.
2
Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.局部结膜上皮内瘤变中局部应用干扰素 alpha 2B 和丝裂霉素 C 的安全性和疗效：其药理安全性和疗效的长期报告。
BMC Ophthalmol. 2023 Jul 27;23(1):335. doi: 10.1186/s12886-023-03092-z.
3
Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.重组干扰素α-2b作为眼表鳞状上皮肿瘤的主要治疗方法
J Curr Ophthalmol. 2021 Oct 22;33(3):260-265. doi: 10.4103/2452-2325.329089. eCollection 2021 Jul-Sep.
4
Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours.眼部肿瘤不同治疗期间及/或之后发生的医源性眼表疾病。
Cancers (Basel). 2021 Apr 16;13(8):1933. doi: 10.3390/cancers13081933.
5
Update on pharmacotherapy for ocular surface squamous neoplasia.眼表鳞状上皮肿瘤药物治疗的最新进展
Eye Vis (Lond). 2019 Aug 12;6:24. doi: 10.1186/s40662-019-0150-5. eCollection 2019.
6
[Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].[类风湿关节炎患者眼表鳞状上皮瘤用α-2b干扰素治疗的并发症]
Ophthalmologe. 2017 Feb;114(2):155-158. doi: 10.1007/s00347-016-0292-y.
7
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.单纯疱疹病毒性上皮性角膜炎的抗病毒治疗及其他治疗干预措施。
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD002898. doi: 10.1002/14651858.CD002898.pub5.
8
Ocular surface tumors.眼表肿瘤
Oman J Ophthalmol. 2009 Jan;2(1):1-2. doi: 10.4103/0974-620X.48414.
本文引用的文献
1
Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.局部应用干扰素α-2b治疗顽固性眼表鳞状上皮肿瘤
Am J Ophthalmol. 2006 Oct;142(4):568-71. doi: 10.1016/j.ajo.2006.05.058.
2
Transient corneal microcysts associated with interferon therapy.与干扰素治疗相关的短暂性角膜微囊肿
Cornea. 2005 May;24(4):480-1. doi: 10.1097/01.ico.0000151566.70731.35.
3
Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.局部应用干扰素α-2b治疗复发性角膜和结膜上皮内瘤变
Ophthalmology. 2004 Sep;111(9):1755-61. doi: 10.1016/j.ophtha.2004.01.034.
4
A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.1例结膜-角膜上皮内瘤变经局部应用丝裂霉素C和干扰素α-2b循环治疗成功。
Cornea. 2004 Jan;23(1):89-92. doi: 10.1097/00003226-200401000-00016.
5
Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.α-2b干扰素成功治疗结膜上皮内瘤变
Jpn J Ophthalmol. 2002 Mar-Apr;46(2):215-7. doi: 10.1016/s0021-5155(01)00494-4.
6
Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
Ophthalmology. 2002 Mar;109(3):548-52. doi: 10.1016/s0161-6420(01)00967-8.
7
Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.局部应用干扰素α-2b使疑似原发性结膜和角膜上皮内瘤消退
Cornea. 2002 Jan;21(1):6-11. doi: 10.1097/00003226-200201000-00003.
8
Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.局部应用干扰素α-2b治疗结膜及角膜上皮内瘤变
Ophthalmology. 2001 Jun;108(6):1093-8. doi: 10.1016/s0161-6420(01)00577-2.
9
Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C.
Cornea. 2000 Jan;19(1):1-6. doi: 10.1097/00003226-200001000-00001.
10
Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells.
J Ocul Pharmacol Ther. 1999 Oct;15(5):401-11. doi: 10.1089/jop.1999.15.401.
Zotero 插件